Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 4|pp. 4033–4051
LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma
Back to articleFigure 3(3 of 12)
100%
Figure 3
Figure 3.The prognostic value of LGALS3BP in KIRC. (A) Disease-free survival in ccRCC patients with high or low LGALS3BP expression (GEPIA2). (B) Overall survival in ccRCC patients with high or low expression of LGALS3BP (GEPIA2).